SCHEMBL13361828

SCHEMBL13361828

N#Cc1ccc(F)cc1N=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 2/20 0.38
▸ MAOA P21397 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ CYP11B2 P19099 3/20 0.37
▸ CYP11B1 P15538 2/20 0.37
▸ AR P10275 1/20 0.36
▸ FFAR4 Q5NUL3 2/20 0.35
▸ FFAR1 O14842 1/20 0.35
▸ USP8 P40818 1/20 0.33
▸ USP7 Q93009 1/20 0.33
▸ USP47 Q96K76 1/20 0.33
▸ SLC22A12 Q96S37 2/20 0.33
▸ CES2 O00748 1/20 0.32
▸ CES1 P23141 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13073880 0.84 TRPV4 (0.34) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL21159847 0.78 MAOB (0.34) TRPV4MAOAMAOBMEN1KMT2A
SCHEMBL13063629 0.76 VCAM1 (0.49) TRPV4MAOAMAOBARMEN1
SCHEMBL13667299 0.76 LMNA (0.45) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL28194580 0.76 AR (0.44) CYP11B2CYP11B1ARCES2KDM4E
SCHEMBL573864 0.73 MAOB (0.53) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL14138229 0.73 CES2 (0.34) CES2CES1CYP1A2KDM4EALDH1A1
SCHEMBL17796265 0.72 TRPV4 (0.42) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL20079389 0.72 LMNA (0.41) MAOAMAOBUSP8USP7SLC22A12
SCHEMBL21100112 0.72 ALDH1A1 (0.36) SLC22A12MEN1KMT2ACYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof WYETH (US) 2009-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270363-A1 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof SEC63, SEC62, SEC22B TRPV4 4725/4885MAOA 3957/4885MAOB 3445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback